23 hours ago
AMPEL BioSolutions is seeking $12.5 million in funding to market LuGene, a personalised blood test that uses genetic information from a patient to predict treatment response and #lupus flares.It is believed LuGene may also be utilised for other autoimmune or inflammatory diseases alongside lupus and AMPEL’s goal is to have LuGene available for regular use by physicians in the next few years. lupusnewstoday.com/2020/01/22/ampel-biosolutions-seeks-funding-to-market-lugene-test-for-lupus/ ... See MoreSee Less
AMPEL BioSolutions Seeks $12.5M to Market its Personalized Blood...
Please click on the link below to visit our Eclipse Light Sensitivity Support Group.
Here you will find practical advice and information on managing light sensitivity.
GO TO ECLIPSE
St James House
Essex RM1 3NH
United Kingdom(00 44) (0)1708 731251Email Us
Information for medical professionals
©2015 LUPUS UK (Registered charity nos. 1051610, SC039682)
Website managed by Ghost Enterprises